← Back to Search

Cognitive Behavioral Therapy for Suicide Attempt

N/A
Waitlist Available
Led By David F Tolin, Ph.D.
Research Sponsored by Hartford Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed on a monthly basis for 6 months follow-up.
Awards & highlights

Study Summary

This trial will compare the efficacy of cognitive behavioral therapy to treatment as usual for inpatient suicide prevention.

Eligible Conditions
  • Attempted Suicide

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at baseline, at completion of inpatient treatment (average of 16 days), and on a monthly basis for 6 months follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at baseline, at completion of inpatient treatment (average of 16 days), and on a monthly basis for 6 months follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Number of Readmissions
Change in Suicidal Behavior
Change in Suicidal Ideation/Intent

Side effects data

From 2021 Phase 4 trial • 12 Patients • NCT04135937
8%
irritability
100%
80%
60%
40%
20%
0%
Study treatment Arm
MESH

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Presence of SUD with BCBTExperimental Treatment1 Intervention
Patients diagnosed with SUD who are randomly assigned to receive BCBT will participate in all aspects of their prescribed treatment plan (i.e., TAU) and will receive up to 4 sessions of CBT (depending on length of stay), lasting 1.5 hours for the first session and 1 hour for the remaining sessions.
Group II: Absence of SUD with BCBTExperimental Treatment1 Intervention
Patients without SUD who are randomly assigned to receive BCBT will participate in all aspects of their prescribed treatment plan (i.e., TAU) and will receive up to 4 sessions of BCBT (depending on length of stay), lasting 1.5 hours for the first session and 1 hour for the remaining sessions.
Group III: Absence of SUD with TAUActive Control1 Intervention
Patients without SUD who are randomly assigned to receive TAU will participate in all aspects of the prescribed treatment plan given by the inpatient unit.
Group IV: Presence of SUD with TAUActive Control1 Intervention
Patients diagnosed with SUD who are randomly assigned to receive TAU will participate in all aspects of the prescribed treatment plan given by the inpatient unit.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cognitive Behavioral Therapy
2016
Completed Phase 4
~3120

Find a Location

Who is running the clinical trial?

American Foundation for Suicide PreventionOTHER
33 Previous Clinical Trials
9,562 Total Patients Enrolled
Hartford HospitalLead Sponsor
133 Previous Clinical Trials
18,719 Total Patients Enrolled
David F Tolin, Ph.D.Principal InvestigatorInstitute of Living/Hartford Hospital
2 Previous Clinical Trials
136 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What eligibility criteria must one fulfill in order to participate in this research?

"The criteria for acceptance in this medical trial requires that participants have attempted suicide and are between 18 and 65 years old. The investigators hope to recruit approximately 200 individuals into the study."

Answered by AI

Does this trial accept participants aged 50 or above?

"According to the study's eligibility standards, patients must be between 18 and 65. In addition, there are 58 clinical studies available for minors and 118 trials designated for those over retirement age."

Answered by AI

Is there a window for interested parties to join this research endeavor?

"According to information posted on clinicaltrials.gov, the recruitment phase for this trial has been concluded; it was initially listed on January 20th 2020 and last modified in May 2nd 2022. While no longer actively recruiting patients, there are currently 169 other medical studies looking for volunteers."

Answered by AI
~41 spots leftby Apr 2025